The “Virtual Patient” system: modeling cancer using deep sequencing technologies for personalized cancer treatment
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The “Virtual Patient” system: modeling cancer using deep sequencing technologies for personalized cancer treatment
Authors
Keywords
-
Journal
Journal fur Verbraucherschutz und Lebensmittelsicherheit-Journal of Consumer Protection and Food Safety
Volume 7, Issue 1, Pages 55-62
Publisher
Springer Nature
Online
2012-01-16
DOI
10.1007/s00003-011-0755-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Markers in the Treatment of Metastatic Colorectal Cancer
- (2010) Peter M. Wilson et al. CANCER JOURNAL
- In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma
- (2010) Jay B Shah et al. Expert Review of Anticancer Therapy
- Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy
- (2010) Liang Cheng et al. Expert Review of Anticancer Therapy
- Integrative analysis of the melanoma transcriptome
- (2010) M. F. Berger et al. GENOME RESEARCH
- Proteomics and ovarian cancer: Integrating proteomics information into clinical care
- (2010) John L. Hays et al. Journal of Proteomics
- Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments
- (2010) Hugues Richard et al. NUCLEIC ACIDS RESEARCH
- Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer
- (2010) D. T. Tsoi et al. ONCOLOGIST
- Characterization of the Melanoma miRNAome by Deep Sequencing
- (2010) Mitchell S. Stark et al. PLoS One
- Accumulation of driver and passenger mutations during tumor progression
- (2010) I. Bozic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- KRAS Testing and Its Importance in Colorectal Cancer
- (2010) Deepa T. Patil et al. Current Oncology Reports
- GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models
- (2009) F. Y. Bois BIOINFORMATICS
- The evolution of tumor metastases during clonal expansion
- (2009) Hiroshi Haeno et al. JOURNAL OF THEORETICAL BIOLOGY
- A small-cell lung cancer genome with complex signatures of tobacco exposure
- (2009) Erin D. Pleasance et al. NATURE
- A comprehensive catalogue of somatic mutations from a human cancer genome
- (2009) Erin D. Pleasance et al. NATURE
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
- (2009) Elaine R. Mardis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptome analysis by strand-specific sequencing of complementary DNA
- (2009) Dmitri Parkhomchuk et al. NUCLEIC ACIDS RESEARCH
- Design and analysis issues in genome-wide somatic mutation studies of cancer
- (2008) Giovanni Parmigiani et al. GENOMICS
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
- (2008) Timothy J. Ley et al. NATURE
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- ConsensusPathDB—a database for integrating human functional interaction networks
- (2008) Atanas Kamburov et al. NUCLEIC ACIDS RESEARCH
- A Global View of Gene Activity and Alternative Splicing by Deep Sequencing of the Human Transcriptome
- (2008) M. Sultan et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started